+467.0%
MRNA vs HRB
-6.2%
+473.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HRB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.5% | +4.8% | +5.3% |
| 7D | -1.1% | -8.0% | +6.9% | +0.8% |
| 30D | +126.1% | -16.0% | +142.1% | +132.4% |
| 3M | +190.0% | +26.9% | +163.2% | +196.2% |
| 6M | +157.2% | +51.1% | +106.1% | +163.1% |
| YTD | +388.2% | +7.1% | +381.1% | +401.7% |
| 1Y | +467.0% | -9.6% | +476.7% | +509.5% |
| All | +467.0% | -6.2% | +473.2% | +509.5% |
Cumulative growth
Daily Returns
Daily percentage return beside HRB.
Daily Out/Under-Performance
Portfolio return minus HRB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HRB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HRB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling